Bill Berners-Lee
Research Subjects
Bill Berners-Lee has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Anna S Tirion
UK Overseas Territories Program, UK Health Security Agency, London, UK
1 shared publicationCaisey Pulford
Blood safety, Hepatitis, STI & HIV Division, UK Health Security Agency
1 shared publicationCaisey V Pulford
Blood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV Division, UK Health Security Agency—Colindale, London, UK
1 shared publication- Christian David Mallen
Keele Staffordshire ST5 5BG School of Medicine and Centre for Musculoskeletal Health Research , Keele University
1 shared publication Dale Weston
UK Overseas Territories Program, UK Health Security Agency, London, UK
1 shared publicationDana Ogaz
Blood safety, Hepatitis, STI & HIV Division, UK Health Security Agency
1 shared publication
Latest Publications
- Open Access
- 28 May 2026
- Published by BMJ in BMJ Public Health
- Vol. 4 (2) , e004552
Qualitative study of barriers and facilitators to Dietary Approaches to Stop Hypertension (DASH) on the Caribbean island of Montserrat
Introduction: Hypertension is the leading modifiable risk factor for cardiovascular disease, with high prevalence in the Eastern Caribbean. Dietary modification is central to prevention and management, with the Dietary Approaches to Stop Hypertension (DASH) diet supported by strong clinical evidence. DASH promotes increased consumption of fruits, vegetables, whole grains, nuts, seeds and pulses while limiting salt, sugar, high-fat meats and dairy, and refined carbohydrates. Although promoted in primary care in Montserrat, adherence may be limited by structural, social and cultural barriers. We aimed to explore the barriers and facilitators experienced by Montserratians attempting to follow the DASH eating plan. Methods: We conducted semi-structured interviews with 16 adults in Montserrat diagnosed with hypertension recruited through primary healthcare providers. Purposive sampling ensured representation across sex and country of birth. Interviews lasting 20–40 min were conducted between June and August 2025, audio-recorded, transcribed verbatim and anonymised. Using a topic guide developed with local and UK experts, participants discussed dietary practices, barriers, facilitators and suggested interventions. Data were analysed using the Theoretical Domains Framework (TDF) through deductive thematic analysis. Results: Participants (aged 40–79) identified five themes shaping DASH adherence: understanding of hypertension and DASH, access to healthy foods, skills and self-efficacy, cultural practices and readiness to change. While hypertension was seen as urgent, cost, availability and seasonality of fruits, vegetables and fish limited adherence. Cooking and cultivation skills supported adherence, though food label literacy was low. Cultural practices and family dynamics both enabled and constrained adherence, and taste preferences often posed barriers. Suggested interventions included nutrition education, financial support, agricultural coordination and peer support. Conclusions: Montserratian adults with hypertension are motivated to improve their diets, but DASH adherence is constrained by financial, logistical, cultural and knowledge barriers. Effective interventions must integrate structural supports with culturally appropriate strategies, developed collaboratively with stakeholders, to ensure feasibility, acceptability and sustainability.
- 28 May 2026
- Published by BMJ in BMJ Public Health
- Vol. 4 (2) , e004552
Open AccessQualitative study of barriers and facilitators to Dietary Approaches to Stop Hypertension (DASH) on the Caribbean island of Montserrat
Introduction: Hypertension is the leading modifiable risk factor for cardiovascular disease, with high prevalence in the Eastern Caribbean. Dietary modification is central to prevention and management, with the Dietary Approaches to Stop Hypertension (DASH) diet supported by strong clinical evidence. DASH promotes increased consumption of fruits, vegetables, whole grains, nuts, seeds and pulses while limiting salt, sugar, high-fat meats and dairy, and refined carbohydrates. Although promoted in primary care in Montserrat, adherence may be limited by structural, social and cultural barriers. We aimed to explore the barriers and facilitators experienced by Montserratians attempting to follow the DASH eating plan. Methods: We conducted semi-structured interviews with 16 adults in Montserrat diagnosed with hypertension recruited through primary healthcare providers. Purposive sampling ensured representation across sex and country of birth. Interviews lasting 20–40 min were conducted between June and August 2025, audio-recorded, transcribed verbatim and anonymised. Using a topic guide developed with local and UK experts, participants discussed dietary practices, barriers, facilitators and suggested interventions. Data were analysed using the Theoretical Domains Framework (TDF) through deductive thematic analysis. Results: Participants (aged 40–79) identified five themes shaping DASH adherence: understanding of hypertension and DASH, access to healthy foods, skills and self-efficacy, cultural practices and readiness to change. While hypertension was seen as urgent, cost, availability and seasonality of fruits, vegetables and fish limited adherence. Cooking and cultivation skills supported adherence, though food label literacy was low. Cultural practices and family dynamics both enabled and constrained adherence, and taste preferences often posed barriers. Suggested interventions included nutrition education, financial support, agricultural coordination and peer support. Conclusions: Montserratian adults with hypertension are motivated to improve their diets, but DASH adherence is constrained by financial, logistical, cultural and knowledge barriers. Effective interventions must integrate structural supports with culturally appropriate strategies, developed collaboratively with stakeholders, to ensure feasibility, acceptability and sustainability.
- Open Access
An emerging trend in STI Management: Antibiotic STI Post-Exposure Prophylaxis Prevalence and Determinants in Recent Surveys
Objectives: This study aimed to estimate the prevalence of antibiotic post-exposure prophylaxis (STI PEP) use among gay, bisexual and other men who have sex with men (GBMSM) in England, and to identify demographic and behavioural factors associated with STI PEP use among early adopters. Methods: We synthesised individual-level data from nine surveys conducted between 2019 and 2024. To harmonise variables that differed subtly across surveys, we generated composite indicators for STI diagnosis, chemsex, and condomless sex. Multiple imputation was used to address partial missingness; participants missing core sociodemographic data were excluded. The primary outcome was self-reported STI PEP use. We calculated the prevalence of use in each survey and assessed associations using mixed-effects logistic regression. Composite variables were included as random effects if they were found to have an interaction with survey. Results: Across nine surveys with 14,142 participants, STI PEP use prevalence ranged from 3.61% (95% confidence interval (CI): 2.78–4.68%) in RiiSH 2020 to 13.05% (11.85–14.36%) in RiiSH 2024. Use was higher among those aged 40–44 (adjusted odds ratio (aOR) = 1.26; 95% CI: 1.00–1.58) and lower in those under 25 (aOR = 0.56; 0.39–0.82) or over 65 (aOR = 0.64; 0.41–0.99), compared to ages 30–34. Transgender women (aOR = 3.87; 1.75–8.50), Black (aOR = 1.85; 1.34–2.56) and Asian (aOR = 1.43; 1.09–1.88) individuals, and people living with HIV (aOR = 3.40; 2.69–4.31) had higher odds of use, compared with cisgender male, White, and HIV negative individuals, respectively. Chemsex (aOR = 2.15; 1.80–2.56), condomless sex (aOR = 1.59; 1.32–1.92), and recent STI diagnosis (aOR = 1.83; 1.34–2.51) were also associated with use. Conclusion: STI PEP use was more common among those practising behaviours associated with higher STI risk. However, participation and sampling biases limit finding generalisability, particularly to underrepresented groups such as women, ethinic minorities and heterosexuals. This analysis will provide a baseline from which to estimate the impact of the recommendation of doxycycline for STI post-exposure prophylaxis in the UK.
Open AccessAn emerging trend in STI Management: Antibiotic STI Post-Exposure Prophylaxis Prevalence and Determinants in Recent Surveys
Objectives: This study aimed to estimate the prevalence of antibiotic post-exposure prophylaxis (STI PEP) use among gay, bisexual and other men who have sex with men (GBMSM) in England, and to identify demographic and behavioural factors associated with STI PEP use among early adopters. Methods: We synthesised individual-level data from nine surveys conducted between 2019 and 2024. To harmonise variables that differed subtly across surveys, we generated composite indicators for STI diagnosis, chemsex, and condomless sex. Multiple imputation was used to address partial missingness; participants missing core sociodemographic data were excluded. The primary outcome was self-reported STI PEP use. We calculated the prevalence of use in each survey and assessed associations using mixed-effects logistic regression. Composite variables were included as random effects if they were found to have an interaction with survey. Results: Across nine surveys with 14,142 participants, STI PEP use prevalence ranged from 3.61% (95% confidence interval (CI): 2.78–4.68%) in RiiSH 2020 to 13.05% (11.85–14.36%) in RiiSH 2024. Use was higher among those aged 40–44 (adjusted odds ratio (aOR) = 1.26; 95% CI: 1.00–1.58) and lower in those under 25 (aOR = 0.56; 0.39–0.82) or over 65 (aOR = 0.64; 0.41–0.99), compared to ages 30–34. Transgender women (aOR = 3.87; 1.75–8.50), Black (aOR = 1.85; 1.34–2.56) and Asian (aOR = 1.43; 1.09–1.88) individuals, and people living with HIV (aOR = 3.40; 2.69–4.31) had higher odds of use, compared with cisgender male, White, and HIV negative individuals, respectively. Chemsex (aOR = 2.15; 1.80–2.56), condomless sex (aOR = 1.59; 1.32–1.92), and recent STI diagnosis (aOR = 1.83; 1.34–2.51) were also associated with use. Conclusion: STI PEP use was more common among those practising behaviours associated with higher STI risk. However, participation and sampling biases limit finding generalisability, particularly to underrepresented groups such as women, ethinic minorities and heterosexuals. This analysis will provide a baseline from which to estimate the impact of the recommendation of doxycycline for STI post-exposure prophylaxis in the UK.
- Open Access
- 15 July 2025
- Published by BMJ in Sexually Transmitted Infections
- Vol. 102 (1) , 24-31
‘It does fill me with a bit of unease’: a qualitative study of the acceptability, facilitators and barriers to reducing the frequency of screening for asymptomatic sexually transmitted infections among gay, bisexual and other men who have sex with men
Objectives: The study aimed to explore the acceptability of reducing the frequency of asymptomatic Chlamydia trachomatis (Ct) and Neisseria gonorrhoeae (Ng) screening among gay, bisexual, and other men who have sex with men (GBMSM)(Although the term GBMSM is used for convenience, the study also includes nonbinary people who were assigned male at birth who have sex with men.). Additionally, it sought to identify barriers and facilitators to implementing such changes and to develop potential interventions that could support a shift in current screening guidelines. Methods: This qualitative study explored stakeholder perspectives on reducing screening frequency and identified potential interventions that could support future guideline changes of this kind. Semistructured interviews were conducted with 22 GBMSM and 8 professional stakeholders. Data were thematically analysed using the Capabilty, Opportunity, Motivation - Behaviour (COM-B) and Theoretical Domains Framework (TDF). TDF domains were mapped to behaviour change techniques to inform intervention development. Candidate interventions were refined based on acceptability, practicability, effectiveness, affordability, side effects, equity. Results: Overall, GBMSM stakeholder responses to discontinuing asymptomatic Ng and Ct screening tended to be negative, while professional stakeholder opinions were mixed. Reducing the recommended screening frequency to 6 monthly was generally more acceptable to both groups. Barriers and facilitators to guideline changes included issues of knowledge and trust, social influence and identity, context and resources, concerns about consequences and emotional responses and habit. Ten candidate interventions were suggested. These involve providing information, social support, behavioural substitutions and feedback as well as facilitating discussions to resolve concerns. Conclusion: Any reduction in the recommended frequency of asymptomatic screening will encounter a range of interrelated barriers, including knowledge gaps, social influences and emotional factors. We identified evidence-based interventions that could improve acceptance and minimise unintended consequences. Future research should incorporate stakeholder workshops to refine these strategies.
- 15 July 2025
- Published by BMJ in Sexually Transmitted Infections
- Vol. 102 (1) , 24-31
Open Access‘It does fill me with a bit of unease’: a qualitative study of the acceptability, facilitators and barriers to reducing the frequency of screening for asymptomatic sexually transmitted infections among gay, bisexual and other men who have sex with men
Objectives: The study aimed to explore the acceptability of reducing the frequency of asymptomatic Chlamydia trachomatis (Ct) and Neisseria gonorrhoeae (Ng) screening among gay, bisexual, and other men who have sex with men (GBMSM)(Although the term GBMSM is used for convenience, the study also includes nonbinary people who were assigned male at birth who have sex with men.). Additionally, it sought to identify barriers and facilitators to implementing such changes and to develop potential interventions that could support a shift in current screening guidelines. Methods: This qualitative study explored stakeholder perspectives on reducing screening frequency and identified potential interventions that could support future guideline changes of this kind. Semistructured interviews were conducted with 22 GBMSM and 8 professional stakeholders. Data were thematically analysed using the Capabilty, Opportunity, Motivation - Behaviour (COM-B) and Theoretical Domains Framework (TDF). TDF domains were mapped to behaviour change techniques to inform intervention development. Candidate interventions were refined based on acceptability, practicability, effectiveness, affordability, side effects, equity. Results: Overall, GBMSM stakeholder responses to discontinuing asymptomatic Ng and Ct screening tended to be negative, while professional stakeholder opinions were mixed. Reducing the recommended screening frequency to 6 monthly was generally more acceptable to both groups. Barriers and facilitators to guideline changes included issues of knowledge and trust, social influence and identity, context and resources, concerns about consequences and emotional responses and habit. Ten candidate interventions were suggested. These involve providing information, social support, behavioural substitutions and feedback as well as facilitating discussions to resolve concerns. Conclusion: Any reduction in the recommended frequency of asymptomatic screening will encounter a range of interrelated barriers, including knowledge gaps, social influences and emotional factors. We identified evidence-based interventions that could improve acceptance and minimise unintended consequences. Future research should incorporate stakeholder workshops to refine these strategies.